Wird geladen...
Myeloid dendritic cells are major producers of interferon-β in dermatomyositis and may contribute to hydroxychloroquine refractoriness
Dermatomyositis pathogenesis remains incompletely understood, however recent work suggests a predominant type 1 IFN response. We explored dermatomyositis pathogenesis by quantifying inflammatory cells in skin, comparing myeloid versus plasmacytoid dendritic cell release of IFN-β, and assessing myelo...
Gespeichert in:
| Veröffentlicht in: | J Invest Dermatol |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2021
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8316264/ https://ncbi.nlm.nih.gov/pubmed/33675790 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jid.2020.12.032 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|